Cognitive impairment in bipolar disorder: Treatment and prevention strategies

International Journal of Neuropsychopharmacology

Volumn 20, Issue 8, 2017, Pages 670-680

  Solé, Brisa ^a   Jiménez, Esther ^a   Torrent, Carla ^a   Reinares, Maria ^a   Del Mar Bonnin, Caterina ^a   Torres, Imma ^a   Varo, Cristina ^a   Grande, Iria ^a   Valls, Elia ^a   Salagre, Estela ^a   Sanchez Moreno, Jose ^a   Martinez Aran, Anabel ^a   Carvalho, André F ^b   Vieta, Eduard ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Bipolar disorder; Cognitive impairment; Cognitive remediation; Functional remediation

Indexed keywords

CENTRAL NERVOUS SYSTEM AGENTS;

BIPOLAR DISORDER; COGNITIVE DEFECT; HUMAN; NEUROPHARMACOLOGY; NEUROPSYCHOLOGY; PRIORITY JOURNAL; REVIEW; SOCIAL PSYCHOLOGY; COMPLICATION; PSYCHOLOGY;

BIPOLAR DISORDER; COGNITIVE DYSFUNCTION; HUMANS;

EID: 85028694430     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyx032     Document Type: Review

References (120)

1. Alda M, McKinnon M, Blagdon R, Garnham J, MacLellan S, O'Donovan C, Hajek T, Nair C, Dursun S, MacQueen G (2017) Methylene blue treatment for residual symptoms of bipolar disorder: Randomised crossover study. Br J Psychiatry 210:54-60.
2. Amoretti S, Bernardo M, Bonnin CM, Bioque M, Cabrera B, Mezquida G, Sole B, Vieta E, Torrent C (2016) The impact of cognitive reserve in the outcome of first-episode psychoses: 2-year follow-up study. Eur Neuropsychopharmacol 26:1638-1648.
3. Anaya C, Torrent C, Caballero FF, Vieta E, Bonnin CM, Ayuso- Mateos JL (2016) Cognitive reserve in bipolar disorder: Relation to cognition, psychosocial functioning and quality of life. Acta Psychiatr Scand 133:386-398.
4. Arts B, Jabben N, Krabbendam L, vanOs J (2008) Meta-Analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol Med 38:771-785.
5. Balanzá-Martínez V, Rubio C, Selva-Vera G, Martinez-Aran A, Sánchez-Moreno J, Salazar-Fraile J, Vieta E, Tabarés-Seisdedos R (2008) Neurocognitive endophenotypes (endophenocognitypes) from studies of relatives of bipolar disorder subjects: A systematic review. Neurosci Biobehav Rev 32:1426-1438.
6. Balanzá-Martínez V, Selva G, Martínez-Arán A, Prickaerts J, Salazar J, González-Pinto A, Vieta E, Tabarés-Seisdedos R (2010) Neurocognition in bipolar disorders-A closer look at comorbidities and medications. Eur J Pharmacol 626:87-96.
7. Baune BT, Malhi GS (2015) A review on the impact of cognitive dysfunction on social, occupational, and general functional outcomes in bipolar disorder. Bipolar Disord 17:41-55.
8. Berk M, Conus P, Lucas N, Hallam K, Malhi GS, Dodd S, Yatham LN, Yung A, McGorry P (2007) Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord 9:671-678.
9. Berk M, Copolov DL, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson- Hunt M, Bush AI (2008) N-Acetyl cysteine for depressive symptoms in bipolar disorder-A double-blind randomized placebo-controlled trial. Biol Psychiatry 64:468-475.
10. Berk M, Dean OM, Cotton SM, Gama CS, Kapczinski F, Fernandes B, Kohlmann K, Jeavons S, Hewitt K, Moss K, Allwang C, Schapkaitz I, Cobb H, Bush AI, Dodd S, Malhi GS (2012) Maintenance N-Acetyl cysteine treatment for bipolar disorder: A doubleblind randomized placebo controlled trial. BMC Med 10:91.
11. Bobo WV, Woodward ND, Sim MY, Jayathilake K, Meltzer HY (2011) The effect of adjunctive armodafinil on cognitive performance and psychopathology in antipsychotic-Treated patients with schizophrenia/schizoaffective disorder: A randomized, doubleblind, placebo-controlled trial. Schizophr Res 130:106-113.
12. Bonnín CM, Martínez-Arán A, Torrent C, Pacchiarotti I, Rosa AR, Franco C, Murru A, Sanchez-Moreno J, Vieta E (2010) Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: A long-Term, follow-up study. J Affect Disord 121:156-160.
13. Bonnín CM, Sánchez-Moreno J, Martínez-Arán A, Solé B, Reinares M, Rosa AR, Goikolea JM, Benabarre A, Ayuso-Mateos JL, Ferrer M, Vieta E, Torrent C (2011) Subthreshold symptoms in bipolar disorder: impact on neurocognition, quality of life and disability. J Affect Disord 136:650-659.
14. Bonnín CM, Reinares M, Martinez-Aran A, Balanza-Martinez V, Sole B, Torrent C, Tabarés-Seisdedos R, García-Portilla MP, Ibáñez A, Amann BL, Arango C, Ayuso-Mateos JL, Crespo JM, González-Pinto A, Colom F, Vieta E; CIBERSAM Functional Remediation Group (2015) Effects of functional remediation on neurocognitively impaired bipolar patients: Enhancement of verbal memory. Psychol Med 46:291-301.
15. Bonnín CM, Torrent C, Arango C, Amann BL, Sole B, Gonzalez-Pinto A, Crespo JM, Tabarés-Seisdedos R, Reinares M, Ayuso-Mateos JL, García-Portilla MP, Ibañez Á, Salamero M, Vieta E, Martinez-Aran A; CIBERSAM Functional Remediation Group (2016) Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome. Br J Psychiatry 208:87-93.
16. Bora E (2016) Differences in cognitive impairment between schizophrenia and bipolar disorder: considering the role of heterogeneity. Psychiatry Clin Neurosci 70:424-433.
17. Bora E, Hidiroglu C, Özerdem A, Kaçar ÖF, Sarisoy G, Civil Arslan F, Aydemir Ö, Cubukcuoglu Tas Z, Vahip S, Atalay A, Atasoy N, Atesci F, Tümkaya S (2016a) Executive dysfunction and cognitive subgroups in a large sample of euthymic patients with bipolar disorder. EurNeuropsychopharmacol 26:1338-1347.
18. Bora E, Pantelis C (2015) Meta-Analysis of cognitive impairment in first-episode bipolar disorder: comparison with first-episode schizophrenia and healthy controls. Schizophr Bull 41:1095-1104.
19. Bora E, Pantelis C (2016) Social cognition in schizophrenia in comparison to bipolar disorder: A meta-Analysis. Schizophr Res 175:72-78.
20. Bora E, Yucel M, Pantelis C (2009) Cognitive endophenotypes of bipolar disorder: A meta-Analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord 113:1-20.
21. Bora E, Veznedaroglu B, Vahip S (2016b) Theory of mind and executive functions in schizophrenia and bipolar disorder: A cross-diagnostic latent class analysis for identification of neuropsychological subtypes. Schizophr Res 176:500-505.
22. Bortolato B, Miskowiak KW, Köhler CA, Vieta E, Carvalho AF (2015) Cognitive dysfunction in bipolar disorder and schizophrenia: A systematic review of meta-Analyses. Neuropsychiatr Dis Treat 11:3111-3125.
23. Bourne C, Aydemir O, Balanza-Martinez V, Bora E, Brissos S, Cavanagh JT, Clark L, Cubukcuoglu Z, Dias VV, Dittmann S, Ferrier IN, Fleck DE, Frangou S, Gallagher P, Jones L, Kieseppä T, Martínez-Aran A, Melle I, Moore PB, Mur M, et al. (2013) Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: An individual patient data meta-Analysis. Acta Psychiatr Scand 128:149-162.
24. Breitborde NJ, Dawson SC, Woolverton C, Dawley D, Bell EK, Norman K, Polsinelli A, Bernstein B, Mirsky P, Pletkova C, Grucci F 3rd, Montoya C, Nanadiego B, Sarabi E, DePalma M, Moreno F (2014) A randomized controlled trial of cognitive remediation and d-cycloserine for individuals with bipolar disorder. BMC Psychol 2:41.
25. Budde M, Schulze TG (2014) Neurocognitive correlates of the course of bipolar disorder. Harv Rev Psychiatry 22:342-347.
26. Burdick KE, Braga RJ, Nnadi CU, Shaya Y, Stearns WH, Malhotra AK (2012) Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: Targeting cognitive dysfunction. J Clin Psychiatry 73:103-112.
27. Burdick KE, Russo M, Frangou S, Mahon K, Braga RJ, Shanahan M, Malhotra AK (2014) Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications. Psychol Med 44:3083-3096.
28. Burdick KE, Ketter TA, Goldberg JF, Calabrese JR (2015) Assessing cognitive function in bipolar disorder: challenges and recommendations for clinical trial design. J Clin Psychiatry 76:e342-e350.
29. Catalá-López F, Gènova-Maleras R, Vieta E, Tabarés-Seisdedos R (2013) The increasing burden of mental and neurological disorders. Eur Neuropsychopharmacol 23:1337-1339.
30. Chengappa KN, Bowie CR, Schlicht PJ, Fleet D, Brar JS, Jindal R (2013) Randomized placebo-controlled adjunctive study of an extract of withania somnifera forcognitive dysfunction in bipolar disorder. J Clin Psychiatry 74:1076-1083.
31. Craddock N, Owen MJ (2010) The Kraepelinian dichotomy - going, going... but still not gone. Br J Psychiatry 196:92-95.
32. Cuthbert BN (2014) The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry 13:28-35.
33. Daban C, Martinez-Aran A, Torrent C, Tabarés-Seisdedos R, Balanzá- Martínez V, Salazar-Fraile J, Selva-Vera G, Vieta E (2006) Specificity of cognitive deficits in bipolar disorder versus schizophrenia. A systematic review. Psychother Psychosom 75:72-84.
34. Dean OM, Bush AI, Copolov DL, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Berk M (2012) Effects of N-Acetyl cysteine on cognitive function in bipolar disorder. Psychiatry Clin Neurosci 66:514-517.
35. Deckersbach T, Nierenberg AA, Kessler R, Lund HG, Ametrano RM, Sachs G, Rauch SL, Dougherty D (2010) RESEARCH: cognitive rehabilitation for bipolar disorder: An open trial for employed patients with residual depressive symptoms. CNS Neurosci Ther 16:298-307.
36. de la Serna E, Vila M, Sanchez-Gistau V, Moreno D, Romero S, Sugranyes G, Baeza I, Llorente C, Rodriguez-Toscano E, Sánchez-Gutierrez T, Castro-Fornieles J (2016) Neuropsychological characteristics of child and adolescent offspring of patients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 65:54-59.
37. Demant KM, Vinberg M, Kessing LV, Miskowiak KW (2015) Effects of short-Term cognitive remediation on cognitive dysfunction in partially or fully remitted individuals with bipolar disorder: Results of a randomised controlled trial. PloS One 10:e0127955.
38. Depp CA, Strassnig M, Mausbach BT, Bowie CR, Wolyniec P, Thornquist MH, Luke JR, McGrath JA, Pulver AE, Patterson TL, Harvey PD (2014) Association of obesity and treated hypertension and diabetes with cognitive ability in bipolar disorder and schizophrenia. Bipolar Disord 16:422-431.
39. Forcada I, Mur M, Mora E, Vieta E, Bartrés-Faz D, Portella MJ (2015) The influence of cognitive reserve on psychosocial and neuropsychological functioning in bipolar disorder. Eur Neuropsychopharmacol 25:214-222.
40. Fountoulakis KN, Vieta E, Young A, Yatham L, Grunze H, Blier P, Moeller HJ, Kasper S (2016) The International College of Neuropsychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 4: unmet needs in the treatment of bipolar disorder and recommendations for future research. Int J Neuropsychopharmacol pii: pyw072 [Epub ahead of print].
41. Franke AG, Gränsmark P, Agricola A, Schühle K, Rommel T, Sebastian A, Balló HE, Gorbulev S, Gerdes C, Frank B, Ruckes C, Tüscher O, Lieb K (2017) Methylphenidate, modafinil, and caffeine for cognitive enhancement in chess: A double-blind, randomised controlled trial. Eur Neuropsychopharmacol 27:248-260.
42. Fuentes-Durá I, Balanzá-Martínez V, Ruiz-Ruiz JC, Martínez-Arán A, Girón M, Solé B, ánchez-Moreno J, Gómez-Beneyto M, Vieta E, Tabarés-Seisdedos R (2012) Neurocognitive training in patients with bipolar disorders: current status and perspectives. Psychother Psychosom 81:250-252.
43. Ghaemi SN, Gilmer WS, Dunn RT, Hanlon RE, Kemp DE, Bauer AD, Chriki L, Filkowski MM, Harvey PD (2009) A double-blind, placebo-controlled pilot study of galantamine to improve cognitive dysfunction in minimally symptomatic bipolar disorder. J Clin Psychopharmacol 29:291-295.
44. Gildengers AG, Butters MA, Chisholm D, Reynolds CF, Mulsant BH (2008) A 12-week open-label pilot study of donepezil for cognitive functioning and instrumental activities of daily living in late-life bipolar disorder. Int J Geriatr Psychiatry 23:693-698.
45. Goodwin GM, Martinez-Aran A, Glahn DC, Vieta E (2008) Cognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? An ECNP expert meeting report. Eur Neuropsychopharmacol 18:787-793.
46. Goss AJ, Kaser M, Costafreda SG, Sahakian BJ, Fu CH (2013) Modafinil augmentation therapy in unipolar and bipolar depression: A systematic review and meta-Analysis of randomized controlled trials. J Clin Psychiatry 74:1101-1107.
47. Goswami U, Sharma A, Varma A, Gulrajani C, Ferrier IN, Young AH, Gallagher P, Thompson JM, Moore PB (2009) The neurocognitive performance of drug-free and medicated euthymic bipolar patients do not differ. Acta Psychiatr Scand 120: 456- 463.
48. Grande I, Berk M, Birmaher B, Vieta E (2016) Bipolar disorder. Lancet 387:1561-1572.
49. Grande I, Sanchez-Moreno J, Sole B, Jimenez E, Torrent C, Bonnin CM, Varo C, Tabares-Seisdedos R, Balanzá-Martínez V, Valls E, Morilla I, Carvalho AF, Ayuso-Mateos JL, Vieta E, Martinez- Aran A (2017) High cognitive reserve in bipolar disorders as a moderator of neurocognitive impairment. J Affect Disord 208:621-627.
50. Gualtieri CT, Johnson LG (2006) Comparative neurocognitive effects of 5 psychotropic anticonvulsants and lithium. MedGenMed 8:46.
51. Harel EV, Zangen A, Roth Y, Reti I, Braw Y, Levkovitz Y (2011) H-coil repetitive transcranial magnetic stimulation for the treatment of bipolar depression: An add-on, safety and feasibility study. World J Biol Psychiatry 12:119-126.
52. Hellvin T, Sundet K, Simonsen C, Aminoff SR, Lagerberg TV, Andreassen OA, Melle I (2012) Neurocognitive functioning in patients recently diagnosed with bipolar disorder. Bipolar Disord 14:227-238.
53. Iosifescu DV, Moore CM, Deckersbach T, Tilley CA, Ostacher MJ, Sachs GS, Nierenberg AA (2009) Galantamine-ER for cognitive dysfunction in bipolar disorder and correlation with hippocampal neuronal viability: A proof-of-concept study. CNS Neurosci Ther 15:309-319.
54. Jensen JH, Knorr U, Vinberg M, Kessing LV, Miskowiak KW (2016) Discrete neurocognitive subgroups in fully or partially remitted bipolar disorder: Associations with functional abilities. J Affect Disord 205:378-386.
55. Kapczinski F, Vieta E, Cristina A, Frey BN, Gomes FA, Tramontina J, Kauer-Sant'anna M, Grassi-Oliveira R, Post RM (2008) Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev 32:675-692.
56. Kaser M, Deakin JB, Michael A, Zapata C, Bansal R, Ryan D, Cormack F, Rowe JB, Sahakian BJ (2017) Modafinil improves episodic memory and working memory cognition in patients with remitted depression: A double-blind, randomized, placebo- controlled study. Biol Psychiatr Cognitive Neuroscience and Neuroimaging 2:115-122.
57. Keefe RS, McClintock SM, Roth RM, Doraiswamy PM, Tiger S, Madhoo M (2014) Cognitive effects of pharmacotherapy for major depressive disorder: A systematic review. J Clin Psychiatry 75:864-876.
58. Kozicky JM, Torres IJ, Silveira LE, Bond DJ, Lam RW, Yatham LN (2014) Cognitive change in the year after a first manic episode: Association between clinical outcome and cognitive performance early in the course of bipolar I disorder. J Clin Psychiatry 75:e587-e93.
59. Kucyi A, Alsuwaidan MT, Liauw SS, McIntyre RS (2010) Aerobic physical exercise as a possible treatment for neurocognitive dysfunction in bipolar disorder. Postgrad Med 122:107-116.
60. Kurtz MM, Gerraty RT (2009) A meta-Analytic investigation of neurocognitive deficits in bipolar illness: profile and effects of clinical state. Neuropsychology 23:551-562.
61. Lackner N, Bengesser SA, Birner A, Painold A, Fellendorf FT, Platzer M, Reininghaus B, Weiss EM, Mangge H, McIntyre RS, Fuchs D, Kapfhammer HP, Wallner-Liebmann SJ, Reininghaus EZ (2015) Abdominal obesity is associated with impaired cognitive function in euthymic bipolar individuals. World J Biol Psychiatry 17:535-546.
62. Lahera G, Ruiz-Murugarren S, Iglesias P, Ruiz-Bennasar C, Montes M, Ferna A (2012) Social cognition and global functioning in bipolar disorder. J Nerv Ment Dis 200:135-141.
63. Lahera G, Benito A, Montes JM, Fernandez-Liria A, Olbert CM, Penn DL (2013) Social cognition and interaction training (SCIT) for outpatients with bipolar disorder. J Affect Disord 146:132-136.
64. Lee RSC, Hermens DF, Scott J, Redoblado-Hodge MA, Naismith SL, Lagopoulos J, Griffiths KR, Porter MA, Hickie IB (2014). A meta-Analysis of neuropsychological functioning in first-episode bipolar disorders. J Psychiatr Res 57:1-11.
65. Levy B, Monzani BA, Stephansky MR, Weiss RD (2008) Neurocognitive impairment in patients with co-occurring bipolar disorder and alcohol dependence upon discharge from inpatient care. Psychiatry Res 161:28-35.
66. Lewandowski KE, Sperry SH, Ongur D, Cohen BM, Norris LA, Keshavan MS (2016) Cognitive remediation versus active computer control in bipolar disorder with psychosis: study protocol for a randomized controlled trial. Trials 17:136.
67. Lichtenstein P, Yip BH, Björk C, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM (2009) Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: A population-based study. Lancet 373:234-239.
68. López-Jaramillo C, Lopera-Vásquez J, Gallo A, Ospina-Duque J, Bell V, Torrent C, Martinez-Aran A, Vieta E (2010). Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence. Bipolar Disord 12:557-567.
69. Malchow B, Reich-Erkelenz D, Oertel-Knöchel V, Keller K, Hasan A, Schmitt A, Scheewe TW, Cahn W, Kahn RS, Falkai P (2013) The effects of physical exercise in schizophrenia and affective disorders. Eur Arch PsychiatryClin Neurosci 263:451-467.
70. Marshall DF, Passarotti AM, Ryan KA, Kamali M, Saunders EFH, Pester B, McInnis MG, Langenecker SA (2016) Deficient inhibitory control as an outcome of childhood trauma. Psychiatry Res 235:7-12.
71. Martin DM, Chan H, Green MJ, Mitchell PB, Alonzo A, Loo C (2015) Transcranial direct current stimulation (tDCS) to remediate cognitive function in euthymic bipolar disorder patients. Bipolar Disord 17:849-858.
72. Martinez-Aran A, Vieta E (2015) Cognition as a target in schizophrenia, bipolar disorder and depression. Eur Neuropsychopharmacol 25:151-157.
73. Martino DJ, Samamé C, Ibañez A, Strejilevich SA (2015) Neurocognitive functioning in the premorbid stage and in the first episode of bipolar disorder: A systematic review. Psychiatry Res 226:23-30.
74. Matthews JD, Blais M, Park L, Welch C, Baity M, Murakami J, Sklarsky K, Homberger C, Fava M (2008) The impact of galantamine on cognition and mood during electroconvulsive therapy: A pilot study. J Psychiatr Res 42:526-531.
75. Matthews JD, Siefert CJ, Blais MA, Park LT, Siefert CJ, Welch CA, Dubois CM, van Nieuwenhuizen AO, Rooney KO, Seabrook RC, Durham LE, Adams HC, Fava M (2013) A double-blind, placebo-controlled study of the impact of galantamine on anterograde memory impairment during electroconvulsive therapy. J ECT 29:170-178.
76. McIntyre RS, Soczynska JK, Woldeyohannes HO, Miranda A, Vaccarino A, Macqueen G, Lewis GF, Kennedy SH (2012) A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder. Bipolar Disord 14:697-706.
77. Millan MJ, Goodwin GM, Meyer-Lindenberg A, Ove Ögren S (2015) Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders. Eur Neuropsychopharmacol 25:599-656.
78. Minichino A, Bersani FS, Capra E, Pannese R, Bonanno C, Salviati M, Delle Chiaie R, Biondi M (2012) ECT, rTMS, and deepTMS in pharmacoresistant drug-free patients with unipolar depression: A comparative review. Neuropsychiatr Dis Treat 8:55-64.
79. Minichino A, Bersani FS, Bernabei L, Spagnoli F, Vergnani L, Corrado A, Taddei I, Biondi M, Delle Chiaie R (2015) Prefrontocerebellar transcranial direct current stimulation improves visuospatial memory, executive functions, and neurological soft signs in patients with euthymic bipolar disorder. Neuropsychiatr Dis Treat 11:2265-2270.
80. Miskowiak KW, Ehrenreich H, Christensen EM, Kessing LV, Vinberg M (2014) Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: A double-blind, randomized, placebo-controlled phase 2 trial. J Clin Psychiatry 75:1347-1355.
81. Miskowiak KW, Carvalho AF, Vieta E, Kessing LV (2016) Cognitive enhancement treatments for bipolar disorder: A systematic review and methodological recommendations. Eur Neuropsychopharmacol 26:1541-1561.
82. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG (2010) CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 340:c869.
83. Passos IC, Mwangi B, Vieta E, Berk M, Kapczinski F (2016) Areas of controversy in neuroprogression in bipolar disorder. Acta Psychiatr Scand 134:91-103.
84. Rapado-Castro M, Dodd S, Bush AI, Malhi GS, Skvarc DR, On ZX, Berk M, Dean OM (2016) Cognitive effects of adjunctive N-Acetyl cysteine in psychosis. Psychol Med 29:1-11.
85. Reinares M, Sánchez-Moreno J, Fountoulakis KN (2014) Psychosocial interventions in bipolar disorder: What, for whom, and when. J Affect Disord 156:46-55.
86. Robinson LJ, Thompson JM, Gallagher P, Goswami U, Young AH, Ferrier IN, Moore PB (2006) A meta-Analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord 93:105-115.
87. Rosa AR, Magalhães PVS, Czepielewski L, Sulzbach MV, Goi PD, Vieta E, Gama CS, Kapczinski F (2014) Clinical staging in bipolar disorder: Focus on cognition and functioning. J Clin Psychiatry 75:450-456.
88. Rosenblat JD, Kakar R, McIntyre RS (2015) The cognitive effects of antidepressants in major depressive disorder: A systematic review and meta-Analysis of randomized clinical trials. Int J Neuropsychopharmacol 19:1-13.
89. Rybakowski JK, Suwalska A (2010) Excellent lithium responders have normal cognitive functions and plasma BDNF levels. Int J Neuropsychopharmacol 13:617-622.
90. Salagre E, Vieta E, Grande I (2017) The visceral brain: bipolar disorder and microbiota. Rev Psiquiatr Salud Ment. Mar 22. pii: S1888-9891(17)30029-0. doi: 10.1016/j.rpsm.2017.02.001.
91. Samamé C, Martino DJ, Strejilevich SA (2012) Social cognition in euthymic bipolar disorder: systematic review and meta-Analytic approach. Acta Psychiatr Scand 125:266-280.
92. Samamé C, Martino DJ, Strejilevich SA (2014) Longitudinal course of cognitive deficits in bipolar disorder: A meta-Analytic study. J Affect Disord 164:130-138.
93. Samamé C, Martino DJ, Strejilevich SA (2015) An individual task meta-Analysis of social cognition in euthymic bipolar disorders. J Affect Disord 173:146-153.
94. Sanches M, Bauer IE, Galvez JF, Zunta-Soares GB, Soares JC (2015) The management of cognitive impairment in bipolar disorder: current status and perspectives. Am J Ther 22:477-486.
95. Sanchez-Moreno J, Martinez-Aran A, Colom F, Scott J, Tabares- Seisdedos R, Sugranyes G, Torrent C, Daban C, Benabarre A, Goikolea JM, Franco C, González-Pinto A, Ayuso-Mateos JL, Vieta E (2009) Neurocognitive dysfunctions in euthymic bipolar patients with and without prior history of alcohol use. J Clin Psychiatry 70:1120-1127.
96. Sanchez-Moreno J, Bonnín C, González-Pinto A, Amann BL, Solé B, Balanzá-Martínez V, Arango C, Jimenez E, Tabarés-Seisdedos R, Garcia-Portilla MP, Ibáñez A, Crespo JM, Ayuso-Mateos JL, Vieta E, Martinez-Aran A, Torrent C; CIBERSAM Functional Remediation Group (2017) Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study. Eur Neuropsychopharmacol. Advance online publication. Jan 23. pii: S0924-977X(17)30024-X. doi: 101016/j.euroneuro.2017.01.010.
97. Sanchez-Moreno J, Martinez-Aran A, Vieta E (2017) Treatment of functional impairment in patients with bipolar disorder. Curr Psychiatry Rep 19:3.
98. Silva KL, Rovaris DL, Guimaraes-da-Silva PO, Victor MM, Salgado CA, Vitola ES, Contini V, Bertuzzi G, Picon FA, Karam RG, Belmonte- de-Abreu P, Rohde LA, Grevet EH, Bau CH (2014) Could comorbid bipolar disorder account for a significant share of executive function deficits in adults with attention-deficit hyperactivity disorder? Bipolar Disord 16:270-276.
99. Slyepchenko A, Maes M, Jacka FN, Köhler CA, Barichello T, McIntyre RS, Berk M, Grande I, Foster JA, Vieta E, Carvalho AF (2017) Gut microbiota, bacterial translocation, and interactions with diet: pathophysiological links between major depressive disorder and non-communicable medical comorbidities. Psychother Psychosom 86:31-46.
100. Solé B, Bonnin CM, Mayoral M, Amann BL, Torres I, González- Pinto A, Jimenez E, Crespo JM, Colom F, Tabarés-Seisdedos R, Reinares M, Ayuso-Mateos JL, Soria S, Garcia-Portilla MP, Ibañez Á, Vieta E, Martinez-Aran A, Torrent C; CIBERSAM Functional Remediation Group (2015) Functional remediation for patients with bipolar II disorder: improvement of functioning and subsyndromal symptoms. Eur Neuropsychopharmacol 25:257-264.
101. Solé B, Jiménez E (2015) Tratamiento antipsicótico y aspectos neurocognitivos. Psiquiatria Biologica 22:36-38.
102. Solé B, Jiménez E, Torrent C, Bonnin CM, Torres I, Reinares M, Reinares M, Priego Á, Salamero M, Colom F, Varo C, Vieta E, Martínez-Arán A (2016) Cognitive variability in bipolar II disorder: Who is cognitively impaired and who is preserved. Bipolar Disord 18:288-299.
103. Stange JP, Eisner LR, Hölzel BK, Peckham AD, Dougherty DD, Rauch SL, Nierenberg AA, Lazar S, Deckersbach T (2011) Mindfulness- based cognitive therapy for bipolar disorder: Effects on cognitive functioning. J Psychiatr Pract 17:410-419.
104. Stern, Y (2009) Cognitive reserve. Neuropsychologia 47:2015-28.
105. Strawbridge R, Fish J, Halari R, Hodsoll J, Reeder C, Macritchie K, McCrone P, Wykes T, Young AH (2016) The Cognitive Remediation in Bipolar (CRiB) pilot study: study protocol for a randomised controlled trial. Trials 17:371.
106. Torrent C, Martinez-Arán A, Bonnin CM, Reinares M, Daban C, Solé B, Rosa AR, Tabarés-Seisdedos R, Popovic D, Salamero M, Vieta E (2012). Long-Term outcome of cognitive impairment in bipolar disorder. J Clin Psychiatry 73:e899-e905.
107. Torrent C, et al. (2013) Efficacy of functional remediation in bipolar disorder: A multicenter randomized controlled study. Am J Psychiatry 170:852-859.
108. Torres IJ, Defreitas VG, Defreitas CM, Anna MK, Bond DJ, Honer WG, Lam RW, Yatham LN (2010) Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode. J Clin Psychiatry 71:1234-1242.
109. Tse S, Chan S, Ng KL, Yatham LN (2014) Meta-Analysis of predictors of favorable employment outcomes among individuals with bipolar disorder. Bipolar Disord 16:217-229.
110. van Gorp WG, Altshuler L, Theberge DC, Wilkins J, Dixon W (1998) Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study. Arch Gen Psychiatry 55:41-6.
111. Vieta E (2015) Staging and psychosocial early intervention in bipolar disorder. Lancet Psychiatry 2:483-485.
112. Vieta E (2016) DSM-5.1. Acta Psychiatr Scand 134:187-188.
113. Volkert J, Kopf J, Kazmaier J, Glaser F, Zierhut KC, Schiele MA, Kittel-Schneider S, Reif A (2015) Evidence for cognitive subgroups in bipolar disorder and the influence of subclinical depression and sleep disturbances. Eur Neuropsychopharmacol 25:192-202.
114. Watson S, Gallagher P, Porter RJ, Smith MS, Herron LJ, Bulmer S; North-East Mood Disorders Clinical Research Group., Young AH, Ferrier IN (2012) A randomized trial to examine the effect of mifepristone on neuropsychological performance and mood in patients with bipolar depression. Biol Psychiatry 72:943-949.
115. Wingo AP, Wingo TS, Harvey PD, Baldessarini RJ (2009) Effects of lithium on cognitive performance: A meta-Analysis. J Clin Psychiatry 70:1588-1597.
116. Yager J, Feinstein RE (2016) Potential applications of the National Institute of Mental Health's Research Domain Criteria (RDoC) to Clinical psychiatric practice: how RDoC might be used in assessment, diagnostic processes, case formulation, treatment planning, and clinical notes. J Clin Psychiatry Dec 20. doi: 10.4088/JCP.15nr10476.
117. Yatham LN, Mackala S, Basivireddy J, Ahn S, Walji N, Hu C, Lam RW, Torres IJ (2017) Lurasidone versus treatment as usual for cognitive impairment in euthymic patients with bipolar I disorder: A randomised, open-label, pilot study. Lancet Psychiatry 4:208-217.
118. Yim CY, Soczynska JK, Kennedy SH, Woldeyohannes HO, Brietzke E, Mcintyre RS (2012) The effect of overweight/obesity on cognitive function in euthymic individuals with bipolar disorder. Eur Psychiatry 27:223-228.
119. Young AH, Gallagher P, Watson S, Del-Estal D, Owen BM, Ferrier IN (2004) Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder. Neuropsychopharmacology 29:1538-1545.
120. Zyto S, Jabben N, Schulte PF, Regeer BJ, Kupka RW (2016) A pilot study of a combined group and individual functional remediation program for patients with bipolar i disorder. J Affect Disord 194:9-15.